Alexander Eggermont, M.D., Ph.D.

Dr. Eggermont is the Professor of Immunotherapy at University Medical Center Utrecht and the Chief Scientific Officer of the Princess Máxima Center for Pediatric Oncology. He previously served as the General Director of the Gustave Roussy Cancer Center Campus Grand Paris, where he developed Europe’s largest Phase 1-2 drug and immunotherapy development program. Dr. Eggermont is also an Emeritus Professor of Oncology at Paris-Sud University, Emeritus Professor of Oncological Surgery at Erasmus University Rotterdam and a Fellow of the National Institutes of Health’s National Cancer Institute (NIH-NCI). Dr. Eggermont has served as President of ECCO, President of the EORTC, was a member of the Board of Directors of ASCO, served on the Editorial Board of the Journal of Clinical Oncology, and is currently Editor-in-Chief of the European Journal of Cancer. He has published more than 900 peer-reviewed papers and his expertise has been acknowledged by many professional awards throughout his career.